Select pharma shares rally on heavy volumes

SPARC, Wockhardt, GlaxoSmithKline Pharma, Indoco Remedies and Natco Pharma have rallied 5-10% on BSE.

SI Reporter Mumbai
Last Updated : Dec 02 2014 | 1:59 PM IST
Shares of select pharmaceutical companies Sun Pharma Advanced Research Company (SPARC), Wockhardt, GlaxoSmithKline Pharmaceuticals, Indoco Remedies and Natco Pharma have rallied between 5-10% on back of heavy volumes in otherwise subdued market on BSE.

At 13:29 hours, S&P BSE Healthcare index, the largest gainer among sectoral indices, was up 1% or 113 points as compared to 0.40% or 114 points decline in the benchmark S&P BSE Sensex.

SPARC has surged 10% to Rs 200 after the company announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter to its New Drug Application (NDA) for Latanoprost BAK-free eyedrops.

The stock hit a high of Rs 209 in early morning deals and has seen over ten-fold jump in trading volumes. A combined 4.57 million shares representing 2% of total equity of the company changed hands so far.

Wockhardt rallied over 8% to Rs 929, on back of three-fold rise in trading volumes on BSE.  The stock hit a 52-week high of Rs 939 in intra-day trade and has seen a combined 4.55 million shares changing hands on the counter on NSE and BSE.

The stock gained 12% in past three trading sessions from Rs 828 after the NSE included the company in its futures & options (F&O) segment from November 28.

Among the other individual stocks, GlaxoSmithKline Pharmaceuticals has surged 7% to Rs 3,180, followed by Indoco Remedies and Natco Pharma, which are up 5% each at Rs 308 and Rs 1,409 respectively.

Aurobindo Pharma, Torrent Pharmaceuticals, Cadila Healthcare, Glenmark Pharmaceuticals, Biocon, Strides Arcolab, Ipca Laboratories and Ranbaxy Laboratories up 1-3%.
 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 02 2014 | 1:53 PM IST

Next Story